Bob Twillman PhD FAPM Executive Director American Academy of Pain Management Chair Advisory Committee Kansas Prescription Drug Monitoring Program KTRACS Prescription Drug Abuse is a ID: 753518
Download Presentation The PPT/PDF document "Prescription drug abuse" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Prescription drug abuse
Bob Twillman, Ph.D., FAPMExecutive DirectorAmerican Academy of Pain ManagementChair, Advisory CommitteeKansas Prescription Drug Monitoring Program (K-TRACS)Slide2
Prescription Drug Abuse is a Major Public Health Problem
12.5 million non-medical users of opioid pain relievers per year$70-120 billion cost per yearIncreasingly seen as a gateway (or, at least, a waystation) to heroin abuseSlide3
Overdose Deaths Involving Prescription Drugs
CDC estimates that 16,007 Americans died of overdoses involving opioid pain relievers in 2012Statistics are somewhat “squishy” due to reliance on death certificatesUsually called “prescription painkiller overdose deaths” by the media and advocates for reducing opioid useSlide4
Overdose Deaths Involving Prescription Drugs: Not Just the Prescription Opioids
Yet, previous CDC research suggests that about 75-80% of decedents used multiple drugs, not including alcohol, and that as many as 55-60% did not have a prescription for the drugs involvedAmong drug overdose decedents in Florida in the first half of 2013, the state medical examiners’ network reported that 93.5% had multiple drugs on boardSlide5
How Do We Explain This?
CDC graph of opioid sales, overdose deaths, and treatment admissions
NSDUH data: Non-medical use, opioid use disorder rates (%) in people
>
12 years oldSlide6
Another CDC Observation
Prescription opioids misused > 200 days per year rose from 2.2/1000 in 2002-03 to 3.8/1000 in 2009-10 (74.6% increase)Perhaps it’s not that more people are dying because more people are misusing. It’s that more people are dying because people are misusing more/more often/in different ways/all of the abovePeople misusing > 200 days/year are more likely to abuse by inhalation or injectionJones CM :
Arch Intern Med
2012:172(16):1265-7Slide7
Chronic Pain is a Major Public Health Problem
>100 million with chronic pain, ~39 million adults with daily chronic pain, ~10 million disabled$560-635 billion cost per year
Suicide
risk
2.5 to 4X higher
than in those without chronic pain
39,500 suicide deaths in 2011
~
20,000
were people with chronic painSlide8
Two Public Health Problems: More
Commonalities than DifferencesPrescription drug abuse and chronic pain are more alike than different:Both are highly prevalentBoth are very costly, in economic and human termsBoth highly stigmatized, and patients are blamedBoth involve tremendous sufferingBoth are poorly understood by the medical professionBoth are under-resourced vis-à-vis treatmentBoth are complex problems, with many moving parts
Both are best
understood from
a biopsychosocial perspectiveSlide9
Not A Zero-Sum Game
Often, it feels like any attempt to rein in prescription drug abuse must, of necessity, rein in opioid prescribing, even for people with painSimilarly, it often seems as though any effort to improve pain management must involve increased opioid prescribing, which could, in turn, lead to increased prescription drug abuseI believe this mis-states the case, and that it is possible to address both problems without adversely affecting eitherSlide10
A Thought
“For every complex problem, there is a solution that is neat, simple, and wrong”—H.L. MenckenI believe that implementing overly simplistic policy solutions for these two very complex problems leads to the zero-sum game that we so often perceivePerhaps the solutions we should be seeking are as complex as the problems we are trying to solveSlide11
Good Pain Management Helps Prevent Prescription Drug Abuse
Appropriate treatment for chronic pain is multimodal and involves multiple providersThis kind of treatment focuses primarily on improving function, recognizing that this can happen even with minimal (or no) improvement in pain intensityUsing multiple types of treatment should reduce reliance on opioid analgesics as the primary (and sometimes only) means of treating painMultiple barriers exist to providing this type of care for chronic painPolicy change is necessarySlide12
State Pain Policy Advocacy Network (SPPAN)
A project of the American Academy of Pain Management, focused on promoting good state pain policyMore than 120 participating organizations
For more information, visit sppan.aapainmanage.org or contact Amy Goldstein, SPPAN Director, at agoldstein@aapainmanage.orgSlide13
State Pain Management Policy Issues
(as of June 25, 2015)**Prescription Drug Monitoring Programs (35 states/110 bills/34 passed)Good Samaritan/Naloxone Distribution and Administration/Safe Disposal (46/228/?)Abuse-Deterrent Formulations of Opioids (30/45/3)Prescribing Guidelines (16/28/2)Mandatory CME/CE (16/31/3)Pain Clinic Regulation (12/23/6)Reimbursement for integrative pain care (34/46/8+)
Prior Authorization
(29/67/11+)
Step
Therapy/Specialty
Tier
(26/49/5)Slide14
Prescription Drug Monitoring Programs
Prescription drug monitoring programs are now authorized in 49 states, DC, and GuamNot yet fully operational in DC, NEProgram in PA has been limited to C-II meds and only law enforcement access to data, but legislation to update the program passed last yearNot authorized in MO29 states currently share data through the NABP PMPInterConnect program2 additional states with MOUs executed
3 additional states with pending MOUs
2 involved with another
data sharing hubSlide15
State
PDMP StatusJune 26, 2015
PMP Pending
PMP Operating
No PMP
DC
Partially ImplementedSlide16
PMP Interconnect Status
June 26, 2015 (29 States)
MOU Executed
PMPI Operating
MOU Pending
DCSlide17
PDMPs
as public safety toolsMost people think of PDMPs as tools designed to catch “doctor shoppers”This line of thought has been vital to getting legislation establishing PDMPs passedBut, “doctor shoppers” represent a tiny percentage of patients in a PDMP
, and a
small
percentage of queries are from law enforcement
One study found “doctor shoppers” to constitute 0.7% of opioid purchasers, 1.9% of prescriptions, and 4% of opioids by weightSlide18
PDMPs as healthcare delivery tools
PDMPs are very useful healthcare delivery toolsHelp reassure prescribers that patients are behaving appropriatelyHelp diagnose substance use disordersHelp ensure patient safety by revealing possible drug interactionsIn Kansas, HCPs submit 99.97% of queriesSlide19
Prescription Monitoring Programs:Trends in Legislation
Increased interest in:Mandatory registration and useAllowing interstate data sharingAllowing delegates to obtain reportsImproved unsolicited reportingExpanding access to other relevant professionalsShortening reporting intervalsEstablishing secure ongoing fundingEstablishing multidisciplinary advisory committeesIntegration with EHRs and HIEs is viewed as a major priority in many states and in the PMP communitySlide20
Using Complementary Tools
with the PDMPPDMPs provide great information, but they do not provide the complete picture—cannot distinguish
between abuse
, dependence, tolerance, addiction, for
instance
Using
complementary tools can be very
important
Chief
among these tools is urine drug testing
PDMPs tell you what SHOULD
BE
in the patient’s
body
Urine
drug testing tells you what IS in the patient’s
body
Comparing these can be enlighteningSlide21
Using Complementary Tools
With the PDMPComplementing the PDMP report with information obtained from the patient’s family (when appropriate and with permission) also can be helpful
Discussing
the patient with previous prescribers, especially if the patient
has not
revealed them, may be very
important
Reviewing
the report with the patient can provide information about the effectiveness and side effects of previous treatments, increasing efficiencySlide22
PDMPs are only part of the solution
PDMPs are an important tool, but we also need:Better education for healthcare providers and patientsBetter payment for non-medication pain treatments Wider use of abuse-deterrent opioid formulationsGreater use of substance
abuse
screening tools in medical settings
Greater access to effective
substance abuse
A
cultural change with respect to how we expect medicines and healthcare providers to help us
A greater emphasis on prevention of both substance use disorders and chronic pain
And other approaches…Slide23
Thank you for your attention